Sang Taek Jung (Sang Teak Jung)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 19

Top Venues

Molecular pharmaceutics

Experimental & molecular medicine

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Journal of agricultural and food chemistry

Korea University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Korea University Mar 01 2019

South Korea

Associate Professor :: Biomedical Sciences

Kookmin University Sep 01 2012 - Feb 28 2019

South Korea

Associate Professor

Publications

Mei Huang, Jisoo Park, Jina Seo, Sanghwan Ko, Yoon Hee Yang, Yeaji Lee, Hyo Jeong Kim, Bok-Soon Lee, Yun Sang Lee, Byoung Joon Ko, Sang Taek Jung, Deachan Park, Tae Hyeon Yoo, Chul-Ho Kim
An epidermal growth factor receptor-targeting immunotoxin based on IgG shows potent antitumor activity against head and neck cancer. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (13) (2024)
Jisun Lee, Bomi Kim, Hye-Min Woo, Jun-Won Kim, Inji Jung, Seong-Wook Park, Yong-Sung Kim, Jung-Hyun Na, Sang Taek Jung
Enhanced Omicron Variant Neutralization by a Human Antibody Tailored to Wild-Type and Delta-Variant SARS-CoV-2 RBDs. Molecular pharmaceutics 21 (9) (2024)
Jisun Lee, Bomi Kim, Hye-Min Woo, Jun-Won Kim, Inji Jung, Seong-Wook Park, Yong-Sung Kim, Jung-Hyun Na, Sang Taek Jung
Enhanced Omicron Variant Neutralization by a Human Antibody Tailored to Wild-Type and Delta-Variant SARS-CoV-2 RBDs. Molecular pharmaceutics (2024)
Wonju Lee, Sang Min Lee, Sang Taek Jung
Unlocking the Power of Complement-Dependent Cytotoxicity: Engineering Strategies for the Development of Potent Therapeutic Antibodies for Cancer Treatments. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2023)
Ji Yeon Ha, Kwang-Jin Chun, Sanghwan Ko, Ho Won Lee, Ok Kyung Hwang, Chung Su Lim, Kyungsoo Ha, Byoung Joon Ko, Sang Taek Jung
Glycan-Controlled Human PD-1 Variants Displaying Broad-Spectrum High Binding to PD-1 Ligands Potentiate T Cell. Molecular pharmaceutics (2023)
Woo Sung Kim, Ji Hyun Kim, Jisun Lee, Su Yeon Ka, Hee Do Chae, Inji Jung, Sang Taek Jung, Jung-Hyun Na
Functional Expression of the Recombinant Spike Receptor Binding Domain of SARS-CoV-2 Omicron in the Periplasm of Escherichia coli . Bioengineering (Basel, Switzerland) 9 (11) (2022)
Sanghwan Ko, Sora Park, Myung Ho Sohn, Migyeong Jo, Byoung Joon Ko, Jung-Hyun Na, Hojin Yoo, Ae Lee Jeong, Kyungsoo Ha, Ju Rang Woo, Chungsu Lim, Jung Hyu Shin, Dohyun Lee, So-Young Choi, Sang Taek Jung
An Fc variant with two mutations confers prolonged serum half-life and enhanced effector functions on IgG antibodies. Experimental & molecular medicine 54 (11) (2022)
Hyo-Jung Lee, Kwon-Ho Song, Se Jin Oh, Suyeon Kim, Eunho Cho, Jungwon Kim, Yun Gyu Park, Kyung-Mi Lee, Cassian Yee, Seung-Hwa Song, Suhwan Chang, Jungmin Choi, Sang Taek Jung, Tae Woo Kim
Targeting TCTP sensitizes tumor to T cell-mediated therapy by reversing immune-refractory phenotypes. Nature communications 13 (1) (2022)
Minjong Lee, Byunghwa Kang, Juhwa Lee, Jisun Lee, Sang Taek Jung, Chang Yun Son, Seung Soo Oh
De novo selected hACE2 mimics that integrate hotspot peptides with aptameric scaffolds for binding tolerance of SARS-CoV-2 variants. Science advances 8 (43) (2022)
Sanghwan Ko, Man-Seok Ju, Hye-Mi Ahn, Jung-Hyun Na, Woo Hyung Ko, Migyeong Jo, Munsu Kyung, Chung Su Lim, Byoung Joon Ko, Won Kyu Lee, Youn-Jae Kim, Sang Taek Jung
Engineered Human Antibody with Improved Endothelin Receptor Type A Binding Affinity, Developability, and Serum Persistence Exhibits Excellent Antitumor Potency. Molecular pharmaceutics (2022)
Sanghwan Ko, Man-Seok Ju, Hye-Mi Ahn, Jung-Hyun Na, Woo Hyung Ko, Migyeong Jo, Munsu Kyung, Chung Su Lim, Byoung Joon Ko, Won Kyu Lee, Youn-Jae Kim, Sang Taek Jung
Engineered Human Antibody with Improved Endothelin Receptor Type A Binding Affinity, Developability, and Serum Persistence Exhibits Excellent Antitumor Potency. Molecular pharmaceutics 20 (2) (2022)
Sanghwan Ko, Man-Seok Ju, Hye-Mi Ahn, Jung-Hyun Na, Woo Hyung Ko, Migyeong Jo, Munsu Kyung, Chung Su Lim, Byoung Joon Ko, Won Kyu Lee, Youn-Jae Kim, Sang Taek Jung
Engineered Human Antibody with Improved Endothelin Receptor Type A Binding Affinity, Developability, and Serum Persistence Exhibits Excellent Antitumor Potency. Molecular pharmaceutics 20 (2) (2022)
Sanghwan Ko, Man-Seok Ju, Hye-Mi Ahn, Jung-Hyun Na, Woo Hyung Ko, Migyeong Jo, Munsu Kyung, Chung Su Lim, Byoung Joon Ko, Won Kyu Lee, Youn-Jae Kim, Sang Taek Jung
Engineered Human Antibody with Improved Endothelin Receptor Type A Binding Affinity, Developability, and Serum Persistence Exhibits Excellent Antitumor Potency. Molecular pharmaceutics 20 (2) (2022)
Man-Seok Ju, Hye-Mi Ahn, Seong-Gu Han, Sanghwan Ko, Jung-Hyun Na, Migyeong Jo, Chung Su Lim, Byoung Joon Ko, Yeon Gyu Yu, Won-Kyu Lee, Youn-Jae Kim, Sang Taek Jung
A human antibody against human endothelin receptor type A that exhibits antitumor potency. Experimental & molecular medicine 53 (9) (2021)
Sanghwan Ko, Migyeong Jo, Sang Taek Jung
Recent Achievements and Challenges in Prolonging the Serum Half-Lives of Therapeutic IgG Antibodies Through Fc Engineering. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 35 (2) (2021)
Sanghwan Ko, Hyunwoo Jeon, Sanghan Yoon, Munsu Kyung, Hyungdon Yun, Jung-Hyun Na, Sang Taek Jung
Discovery of Novel Pseudomonas putida Flavin-Binding Fluorescent Protein Variants with Significantly Improved Quantum Yield. Journal of agricultural and food chemistry 68 (21) (2020)
Migyeong Jo, Sanghwan Ko, Bora Hwang, Sung-Won Min, Ji Yeon Ha, Ji Chul Lee, Se-Eun Jang, Sang Taek Jung
Engineered human FcγRIIa fusion: A novel strategy to extend serum half-life of therapeutic proteins. Biotechnology and bioengineering 117 (8) (2020)
Man-Seok Ju, Sang Taek Jung
Antigen Design for Successful Isolation of Highly Challenging Therapeutic Anti-GPCR Antibodies. International journal of molecular sciences 21 (21) (2020)
Sanghwan Ko, Bora Hwang, Jung-Hyun Na, Jisun Lee, Sang Taek Jung
Engineered Arabidopsis Blue Light Receptor LOV Domain Variants with Improved Quantum Yield, Brightness, and Thermostability. Journal of agricultural and food chemistry 67 (43) (2019)

Sang Taek Jung.css-eqlu8i{font-size:small;padding-left:4px;} (Sang Teak Jung)

Publication Activity (10 Years)

Top Topics

Top Venues

Sang Taek Jung (Sang Teak Jung)